Life sciences stories
The cornerstone commitment should help Longwall Ventures reach a GBP £100 million close and back more UK deep tech start-ups.
The move comes as AI demand drives Britain's data centre operators to expand faster, secure more power and plan larger sites.
It aims to cut the manual work that leaves many connected-device networks exposed, by turning risk data into enforced policy automatically.
AWS customers can now run OpenAI's latest models in production without leaving Bedrock, with pricing and governance folded into existing commitments.
The deal is set to deepen research ties and speed up commercial use of quantum technologies, as Ottawa seeks trusted partners in a sensitive field.
The platform targets manual drug-development bottlenecks, from trial documents to safety case intake, as biopharma seeks faster compliant workflows.
Rising demand for faster AI-ready infrastructure is driving EfficiencyIT's expansion, as Giles Pattison joins to help scale its modular data centre business.
The rankings bolster Altimetrik's push to win larger contracts from drugmakers as life sciences firms seek AI that improves regulated operations.
Search now blends text, images and files as Google rolls out a single AI experience and background agents to over 1 billion users.
Researchers will gain tools to cut literature review and modelling time as Google opens access to experimental Gemini for Science features gradually.
The UK industrial AI company is stepping up its North American push as it seeks to turn existing US customers into broader revenue growth.
Search users will get background AI agents and custom layouts as Google broadens Gemini across its apps, YouTube and Workspace.
Foreign investors are helping drive Taiwan's stock market to record size as chip and AI shares account for more than four-fifths of value.
The tech cluster supports more than 63,000 jobs and could help Canada strengthen domestic supply chains for semiconductors and photonics.
Foreign backers now supply up to 90% of capital in Canada's biggest venture rounds, widening concerns over ownership and economic sovereignty.
The grants are set to speed the rollout of AI tools across healthcare, manufacturing and finance, helping GTA firms reach market sooner.
Ireland's investor appeal held up even as European foreign direct investment fell 7% to a decade low, EY found.
The platform is aimed at regulated industries and sensitive data users, with on-premise and air-gapped deployment to keep control in-house.
Drug makers face new filing deadlines in China, as eligible trial data can now be shielded for up to six years from copycat use.
The pact will widen use of AI in Singapore's public services, schools and labs, while adding new tests on safety, governance and inclusion.